Illumina | ILMN - Operating Expenses


Illumina reported $899M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Agilent USD 1.43B 2M Jun/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Boston Scientific USD 4.13B 72M Sep/2026
Bruker USD 768.9M 44.3M Jun/2026
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Danaher USD 53.62B 1.04B Sep/2026
Dentsply International USD 1.35B 33M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Illumina USD 899M 47M Jun/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Laboratory Of America USD 3.39B 117.6M Sep/2026
Mettler Toledo International USD 739.77M 26.57M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quest Diagnostics USD 2.62B 34M Sep/2026
Quidel USD 646.2M 1.21B Jun/2026
Repligen USD 185.01M 2.01M Sep/2026
Revvity USD 603.55M 24.8M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Standard Biotools USD 30.56M 15.16M Mar/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Waters USD 527M 592M Jun/2026